content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001190128</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001756262</issuerCik>
        <issuerName>TransMedics Group, Inc</issuerName>
        <secFileNumber>001-38891</secFileNumber>
        <issuerAddress>
          <com:street1>200 Minuteman Road</com:street1>
          <com:city>Andover</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>01810</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>978-552-0900</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>James R. Tobin</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>J.P. Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue - 6th Floor</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>20000</noOfUnitsSold>
        <aggregateMarketValue>2917000</aggregateMarketValue>
        <noOfUnitsOutstanding>33359363</noOfUnitsOutstanding>
        <approxSaleDate>08/08/2024</approxSaleDate>
        <securitiesExchangeName>Nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>05/29/2015</acquiredDate>
        <natureOfAcquisitionTransaction>Series F Preferred Stock</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>20000</amountOfSecuritiesAcquired>
        <paymentDate>05/29/2015</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>The shares filed today will be sold by the James R. Tobin 2012 Trust, James R. Tobin as Trustee</remarks>
      <noticeSignature>
        <noticeDate>08/08/2024</noticeDate>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for James R. Tobin</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2933}]
text: 144
  0001190128
  XXXXXXXX
  LIVE
  0001756262
  TransMedics Group, Inc
  001-38891
  200 Minuteman Road
  Andover
  MA
  01810
  978-552-0900
  James R. Tobin
  Director
  Common
  J.P. Morgan Securities LLC
  390 Madison Avenue - 6th Floor
  New York
  NY
  10017
  20000
  2917000
  33359363
  08/08/2024
  Nasdaq
  Common
  05/29/2015
  Series F Preferred Stock
  Issuer
  N
  20000
  05/29/2015
  Cash
  Y
  The shares filed today will be sold by the James R. Tobin 2012 Trust, James R. Tobin as Trustee
  08/08/2024
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for James R. Tobin